What is the stock code for Sumitomo Pharma?
Sumitomo Pharma Co., Ltd. is publicly listed on the Tokyo Stock Exchange under the stock code 4506. Formed through major corporate integrations within the Japanese pharmaceutical sector, Sumitomo Pharma focuses on global research, development, manufacturing, and commercialization of innovative therapeutic drugs targeting psychiatry, neurology, oncology, and women's health.
Related FAQs
Senior engineers specializing in defense electronics, radar systems, naval combat architecture, or tactical computing at Leonardo DRS earn professional salaries and technical compensation packages.
Summit Therapeutics Inc.
Sumitomo Corporation is an authentic, publicly listed multinational enterprise trading actively on major Japanese financial exchanges, including the Tokyo Stock Exchange, where its shares comprise constituents of prominent market indices like the Nik...
Sumitomo is fundamentally a historic Japanese corporate group tracing its origins back centuries through traditional business lineages and merchant networks.
Sumitomo Pharma is widely recognized as a major global research-driven pharmaceutical enterprise dedicated to discovering, developing, and commercializing advanced medical treatments across psychiatry, neurology, oncology, and regenerative medicine.
The average annual salary for a Director-level position at Sumitomo Pharma in the United States is approximately USD 241,514, with typical compensation ranges spanning from USD 160,531 to over USD 250,000 depending on the specific functional division...
Sumitomo Pharma manufactures and commercializes an extensive portfolio of prescription pharmaceutical products focusing heavily on psychiatry, neurology, oncology, and advanced regenerative medicine.
Sumitomo Pharma Co., Ltd. is an authentic publicly traded corporate entity listed on major stock exchanges such as the Tokyo Stock Exchange.
Sumitomo passenger car, light truck, and SUV tires vary in retail price based on tire dimensions, performance ratings, and specific tread designs such as the HTR or Encounter series.